Skip to content

Ketamine: all studies

Page 333 of 449: studies 3,321 to 3,330 of 4,483, newest first. Back to the ketamine overview

Research

Comparison between dexmedetomidine and ketofol in the prevention of postoperative emergence delirium in pediatric patients undergoing orofacial cleft surgery: A randomized controlled trial.

Journal of anaesthesiology, clinical pharmacology 2025 Surabhi, Poonam Kumari, Amarjeet Kumar et al. 1 citation

Emergence delirium (ED) is a common postoperative complication in pediatric patients. To avoid postoperative ED, sedative medications have been utilized in addition to general anesthesia. In this study, the primary objective was to assess the incidence of postoperative emergence of delirium at 0-, 10-, 20-, 30-, and 60-min intervals. Secondary objective was to assess postoperative analgesia (0,...

Neurotoxicity mechanisms and clinical implications of six common recreational drugs.

Frontiers in Pharmacology 2025 Jing Wang, Yulei Hao, Di Ma et al. 14 citations

The recreational abuse of addictive drugs poses considerable challenges to public health, leading to widespread neurotoxicity and neurological dysfunction. This review comprehensively examines the neurotoxic mechanisms, clinical manifestations, and treatment strategies associated with six commonly abused substances: methamphetamine, cocaine, synthetic cathinones, ketamine, nitrous oxide and...

Biological treatments for co-occurring eating disorders and psychological trauma: a systematic review.

Frontiers in Psychiatry 2025 Ella van Beers, Irene de Vries, Caroline Planting et al. 2 citations

Many people with eating disorders report having experienced childhood maltreatment or a traumatic event prior to developing an eating disorder. Although many people with eating disorders have significant traumatic exposure or symptoms of post-traumatic stress disorder, very little research has examined the effects of combined treatments for this group. The purpose of this systematic review was...

Lateral habenula astroglia modulate the potentiating antidepressant-like effects of bright light stimulation in intractable depression.

Frontiers in Pharmacology 2025 Sarah Delcourte, Amel Bouloufa, Renaud Rovera et al. 3 citations

Beside image vision, light plays a pivotal role in regulating diverse non-visual functions, including affective behaviors. Recently, bright light stimulation (BLS) was revealed to be beneficial for treating non-seasonal depression, although its mechanism of action is not fully understood. We developed a novel mouse model of refractory depression, induced through social isolation and chronic...

Inhibition of NMDA receptors and other ion channel types by membrane-associated drugs.

Frontiers in Pharmacology 2025 Elizabeth G. Neureiter, M Quincy Erickson-Oberg, Aparna Nigam et al. 4 citations

N-methyl-D-aspartate receptors (NMDARs) are ligand-gated ion channels present at most excitatory synapses in the brain that play essential roles in cognitive functions including learning and memory consolidation. However, NMDAR dysregulation is implicated in many nervous system disorders. Diseases that involve pathological hyperactivity of NMDARs can be treated clinically through inhibition by...

Associations between psychedelic use and cannabis use disorder in a nationally representative sample.

Drug and Alcohol Dependence 2025 James M Zech, David B. Yaden, Grant Jones 9 citations

Cannabis Use Disorder (CUD) is an increasingly prevalent disorder affecting millions of Americans each year. Psychedelic compounds have recently been investigated for their therapeutic potential in treating substance use disorders, yet no prior work has examined the relationship between naturalistic use of specific psychedelic compounds and rates of disordered cannabis use. Using a nationally...

Interventional approaches to treatment resistant depression (DTR) in children and adolescents: A systematic review and meta-analysis.

Journal of Affective Disorders December 15, 2024 Ethan Faries, Landon A Mabe, Ronald L Franzen et al. 13 citations

Major depressive disorder (MDD) is highly prevalent in youth. Conventional treatment paradigms primarily involve selective serotonin reuptake inhibitors (SSRIs) and psychotherapy, yet a significant proportion of this population exhibits treatment-resistant depression (TRD). In adults, interventional therapies like Electroconvulsive Therapy (ECT), repetitive Transcranial Magnetic Stimulation...

Editorial: Biological Therapies and Eating Disorders.

European Eating Disorders Review December 15, 2024 Hubertus Himmerich, Beate Herpertz-Dahlmann, Sabrina Mörkl 4 citations

Blood-based biomarkers and neuroimaging techniques have improved our understanding of the underlying biology of eating disorders (EDs) and have increased our diagnostic portfolio. This editorial accompanies an article collection on novel biological approaches to treat EDs. The collection covers intermittent theta burst stimulation, therapeutic drug monitoring, pharmacological treatments...

DOI: 10.1002/erv.3166 (opens in new tab) Full text (opens in new tab) Ketamine Anorexia nervosa Binge eating disorder Bulimia nervosa +6

A brief review of complex regional pain syndrome and current management.

Annals of medicine December 1, 2024 Alaa Abd-Elsayed, Cain W Stark, Natasha Topoluk et al. 41 citations

Complex regional pain syndrome (CRPS) is a debilitating chronic pain condition that, although exceedingly rare, carries a significant burden for the affected patient population. The complex and ambiguous pathophysiology of this condition further complicates clinical management and therapeutic interventions. Furthermore, being a diagnosis of exclusion requires a diligent workup to ensure an...

Pharmacotherapeutic strategies for the treatment of anorexia nervosa - novel targets to break a vicious cycle.

Expert Opinion on Pharmacotherapy December 1, 2024 Millie C Kirchberg, Claire Pinson, Guido K W Frank 9 citations

Anorexia nervosa (AN) has one of the highest mortality rates of all mental illnesses. No approved pharmacological treatments exist for AN, but novel neurobiological targets show promise. Studies show that in individuals with AN, there are alterations in brain neurotransmitter signaling, alongside associated mental rigidity and comorbid anxiety and depression. Available and new therapies could...